Catalyst Wire Dossier Catalyst Wire Dossier

Gemfribozil

· Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemfribozil, covering 2013-02-22 to 2013-02-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects [Phase 1]

See pricing